Stimulation of airway and intestinal mucosal secretion by natural coumarin CFTR activators

Frontiers in Pharmacology

Volumn SEP, Issue , 2011, Pages

  Yang, Hong ^a   Xu, Li Na ^b   Liu, Xin ^c   He, Cheng Yan ^c   Fang, Rou Yu ^b   Liu, Jia ^b   Hao, Feng ^b   Ma, Tong Hui ^a,b  

^a LIAONING NORMAL UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Activator; Airway; CFTR; Colon; Coumarins; Fluid secretion; Mucosa

Indexed keywords

ANGELICIN; COUMARIN DERIVATIVE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENISTEIN; OSTHOLE; PENTOSALEN; PRAERUPTORIN A; SCOPARONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COLONIC SECRETION; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG ACTIVITY; DRUG DETERMINATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; LUNG FUNCTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SECRETION (PROCESS); TRACHEA; TRACHEA MUCOSA;

EID: 84860232519     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2011.00052     Document Type: Article

References (28)

1. Berdiev, B. K., Qadri,Y. J., and Benos, D. J. (2009). Assessment of the CFTR and ENaC association. Mol. Biosyst. 5, 123-127.
2. Boucherot, A., Schreiber, R., and Kun-Zelmann, K. (2001). Regulation and properties of KCNQ1 (K(V)LQT1) and impact of the cystic fibrosis transmembrane conductance regu- lator. Membr. Biol. 182, 39-47.
3. Castro-Parodi, M., Levi, L., Dietrich, V., Zotta, E., and Dami- ano, A. E. (2009). CFTR may modulate AQP9 functionality in preeclamptic placentas. Placenta 30, 642-648.
4. Cohn, J. A., Friedman, K. J., Noone, P. G., Knowles, M. R., Silverman, L. M., and Jowell, P. S. (1998). Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N.Engl.J.Med.339, 653-658.
5. Galietta, L. V., Jayaraman, S., and Verkman, A. S. (2001). Cell-based assay for high throughput quanti- tative screening of CFTR chloridetransport agonists. Am. J. Physiol. Cell Physiol. 281, C1734-C1742.
6. Greger, R. (2000). Role of CFTR in the colon. Annu. Rev. Physiol. 62, 467-491.
7. Hanrahan, J. W., and Wioland, M. A. (2004). Revisiting cystic fibrosis transmembrane conductance regu- lator structure and function. Proc. Am. Thorac. Soc. 1, 17-21.
8. He, L., Aleksandrov, A. A., Serohijos, A. W., Hegedus, T., Aleksandrov, L. A., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008). Multi- ple membrane-cytoplasmic domain contacts in the cystic fibrosis trans- membrane conductance regulator (CFTR) mediate regulation of chan- nel gating. J. Biol. Chem. 283, 26383-26390.
9. He, Q., Zhu, J. X., Xing, Y., Tsang, L. L., Yang, N., Rowlands, D. K., Chung, Y. W., and Chan, H. C. (2005). Tetram- ethylpyrazine stimulates cystic fibro- sis transmembrane conductance regulator-mediated anion secretion in distal colon of rodents. World J. Gastroenterol. 11, 4173-4179.
10. Ho, K. (1998). The ROMK-cystic fibro- sis transmembrane conductance regulator connection: new insights into the relationship between ROMK and cystic fibrosis trans- membrane conductance regulator channels. Curr. Opin. Nephrol. Hypertens. 7, 49-58.
11. Hryciw, D. H., and Guggino, W. B. (2000). Cystic fibrosis transmem- brane conductance regulator and the outwardly rectifying chloride chan- nel: a relationship between two chloride channels expressed in epithelial cells. Clin. Exp. Pharmacol. Physiol. 27, 892-895.
12. Hwang, T. C., and Sheppard, D. N. (1999). Molecular pharmacology of the CFTR Cl- channel. Trends Phar- macol. Sci. 20, 448-453.
13. Jovov, B., Ismailov, I. I., Berdiev, B. K., Fuller, C. M., Sorscher, E. J., Dedman, J. R., Kaetzel, M. A., and Benos, D. J. (1995). Interaction between cystic fibrosis transmembrane conductance regulator and outwardly rectified chloride channels. J. Biol. Chem. 270, 29194-29200.
14. Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., and Tsui, L. C. (1989). Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080.
15. Kunzelmann, K. (1999). The cys- tic fibrosis transmembrane conduc- tance regulator and its function in epithelial transport. Rev. Physiol. Biochem. Pharmacol. 137, 1-70.
16. Levin,M. H.,and Verkman,A. S. (2005). CFTR-regulated chloride transport at the ocular surface in living mice measured by potential differences. Invest. Ophthalmol. Vis. Sci. 46, 1428-1434.
17. Li, H., and Sheppard, D. N. (2009). Therapeutic potential of cystic fibro- sis transmembrane conductance regulator (CFTR) inhibitors in poly- cystic kidney disease. BioDrugs 23, 203-216.
18. Ma, T., Vetrivel, L., Yang, H., Pedemonte, N., Zegarra-Moran, O., Galietta, L. J., and Verkman, A. S. (2002). High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high- throughput screening. J. Biol. Chem. 277, 37235-37241.
19. + perme- ability in regulation of Golgi pH. JOP 2, 229-236.
20. Marcet, B., and Boeynaems, J. M. (2006). Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis. Pharmacol. Ther. 112, 719-732.
21. Pratha, V. S., Hogan, D. L., Martensson, B. A., Bernard, J., Zhou, R., and Isenberg, J. I. (2000). Identification of transport abnormalities in duodenal mucosa and duode- nal enterocytes from patients with cystic fibrosis. Gastroenterology 118, 1051-1060.
22. Riordan, J. R. (2008). CFTR function and prospects for therapy. Annu. Rev. Biochem. 77, 701-726.
23. Schultz, B. D., Singh, A. K., Devor, D. C., and Bridges, R. J. (1999). Phar- macology of CFTR chloride channel activity. Physiol. Rev. 79, S109-S144.
24. Song, Y., and Verkman, A. S. (2001). Aquaporin-5 dependent fluid secre- tion in airway submucosal glands. J. Biol. Chem. 276, 41288-41292.
25. Thiagarajah, J. R., and Verkman, A. S. (2003). CFTR pharmacology and its role in intestinal fluid secre- tion. Curr. Opin. Pharmacol. 3, 594-599.
26. Wu, L., Wang, X., Xu, W., Farzaneh, F., and Xu, R. (2009). The struc- ture and pharmacological functions of coumarins and their derivatives. Curr. Med. Chem. 16, 4236-4260.
27. Xu, L., Na, W., Liu, X., Hou, S., Lin, S., Yang, H., and Ma, T. (2008). Identification of natural coumarin compounds that rescue defective ΔF508-CFTR chloride channel gat- ing. Clin. Exp. Pharmacol. Physiol. 35, 878-883.
28. Yang, H., Shelat, A. A., Guy, R. K., Gopinath, V. S., Ma, T., Du, K., Lukacs, G. L., Taddei, A., Folli, C., Pedemonte, N., Galietta, L. J., and Verkman, A. S. (2003). Nanomolar affinity small molecule correctors of defective delta F508-CFTR chloride channel gating. J. Biol. Chem. 278, 35079-35085.